Supply of the drug Tenofovir + Elsulfavirin + Emtricitabine, film-coated tablets, 245 mg + 20 mg + 200 mg as part of the implementation of the Decree of the Government of the Russian Federation dated December 28, 2016 No. 1512 “On approval of the Regulations on the organization of providing persons infected with the human immunodeficiency virus, including in combination with hepatitis B and C viruses, antiviral medicines for medical use and the Regulations on the organization of providing p
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
Official Contract Award for Supply of the drug Tenofovir + Elsulfavirin + Emtricitabine, film-coated tablets, 245 mg + 20 mg + 200 mg as part of the implementation of the Decree of the Government of the Russian Federation dated December 28, 2016 No. 1512 “On approval of the Regulations on the organization of providing persons infected with the human immunodeficiency virus, including in combination with hepatitis B and C viruses, antiviral medicines for medical use and the Regulations on the organization of providing persons with multidrug-resistant tuberculosis with antibacterial and anti-tuberculosis medicines for medical use". Awarded Contractor: АКЦИОНЕРНОЕ ОБЩЕСТВО "ФАРМСТАНДАРТ" (АО "ФАРМСТАНДАРТ"). Procuring Entity: ФЕДЕРАЛЬНОЕ КАЗЕННОЕ УЧРЕЖДЕНИЕ "ФЕДЕРАЛЬНЫЙ ЦЕНТР ПЛАНИРОВАНИЯ И ОРГАНИЗАЦИИ ЛЕКАРСТВЕННОГО ОБЕСПЕЧЕНИЯ ГРАЖДАН" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ. Contract ID: 1970515020226000726. Value: 306,219,298.38 RUB.